Loading…

Clinical consensus on respiratory syncytial virus (RSV) infection prophylaxis and the use of palivizumab in paediatric cardiology.

Following the results of the CIVIC study, the SECPCC proposes to revise its recommendations for the prevention of RSV, taking into account the new evidence, as well as the preventive experience of paediatric cardiologists. For this purpose a structured method of professional consensus has been chose...

Full description

Saved in:
Bibliographic Details
Published in:Anales de pediatría (Barcelona, Spain : 2003) Spain : 2003), 2010-06, Vol.72 (6), p.432.e1-432.13
Main Authors: Medrano López, C, García-Guereta, L, Fernández Pineda, L, Malo Concepción, P, Maroto Alvaro, E, Santos de Soto, J, Lirio Casero, J, Suárez Cabrera, P, Caballero Martínez, F
Format: Article
Language:Spanish
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 432.13
container_issue 6
container_start_page 432.e1
container_title Anales de pediatría (Barcelona, Spain : 2003)
container_volume 72
creator Medrano López, C
García-Guereta, L
Fernández Pineda, L
Malo Concepción, P
Maroto Alvaro, E
Santos de Soto, J
Lirio Casero, J
Suárez Cabrera, P
Caballero Martínez, F
description Following the results of the CIVIC study, the SECPCC proposes to revise its recommendations for the prevention of RSV, taking into account the new evidence, as well as the preventive experience of paediatric cardiologists. For this purpose a structured method of professional consensus has been chosen. To develop a Spanish clinical consensus on preventing infection by RSV under the auspices of the Sociedad Española de Cardiología Pediátrica y Cardiopatías Congénitas. Delphi Consensus modified in two rounds. The study was conducted in four phases: 1) constitution of a Scientific Committee for bibliographic review and submission of the recommendations for discussion, 2) constitution of an Expert Panel with 75 representatives in the speciality, 3) postal survey organised in two rounds and intermediate processing of opinions, and issuing of a report to the panellists, and 4) discussion of the results in a face-to-face meeting of the Scientific Committee. Consensus was reached on 54 of the 70 preventive recommendations analysed. With respect to the 16 remaining issues, no consensus was reached, due to differences in professional opinion and the absence of established criteria among the majority of the experts. A set of recommendations for RSV prophylaxis in cardiology was developed and updated, rated in accordance with the degree of professional consensus on which they were based. These can be considered valid until such time as new scientific information emerges that warrants a further review.
doi_str_mv 10.1016/j.anpedi.2010.03.001
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_733404418</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733404418</sourcerecordid><originalsourceid>FETCH-LOGICAL-p140t-303422c8095633d91dc9d6b145cfbdf16583b222335bba55bed8ee478d0ab0ff3</originalsourceid><addsrcrecordid>eNo1kEtLxDAUhYMgzjj6D0SyUxetebbpUgZfMCD42pa86mTopDVpB-vSX27AcXW493z3cjgAnGGUY4SL600ufW-NywlKK0RzhPABmOOi4lnFKZ6B4xg3CBFRkPIIzAhiFS2FmIOfZeu807KFuvPR-jhG2HkYbOxdkEMXJhgnr6fBJWTnQrIvn1_er6DzjdWDS2wfun49tfLLRSi9gcPawjFa2DWwl63bue9xK1U6SGPKKIfgNNQyGNe13ceUn4DDRrbRnu51Ad7ubl-XD9nq6f5xebPKeszQkFFEGSFaoIoXlJoKG12ZQmHGdaNMgwsuqCKEUMqVkpwra4S1rBQGSYWahi7Axd_fFPhztHGoty5q27bS226MdUkpQ4xhkcjzPTmqrTV1H9xWhqn-r43-AsS3chs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733404418</pqid></control><display><type>article</type><title>Clinical consensus on respiratory syncytial virus (RSV) infection prophylaxis and the use of palivizumab in paediatric cardiology.</title><source>ScienceDirect (Online service)</source><creator>Medrano López, C ; García-Guereta, L ; Fernández Pineda, L ; Malo Concepción, P ; Maroto Alvaro, E ; Santos de Soto, J ; Lirio Casero, J ; Suárez Cabrera, P ; Caballero Martínez, F</creator><creatorcontrib>Medrano López, C ; García-Guereta, L ; Fernández Pineda, L ; Malo Concepción, P ; Maroto Alvaro, E ; Santos de Soto, J ; Lirio Casero, J ; Suárez Cabrera, P ; Caballero Martínez, F</creatorcontrib><description>Following the results of the CIVIC study, the SECPCC proposes to revise its recommendations for the prevention of RSV, taking into account the new evidence, as well as the preventive experience of paediatric cardiologists. For this purpose a structured method of professional consensus has been chosen. To develop a Spanish clinical consensus on preventing infection by RSV under the auspices of the Sociedad Española de Cardiología Pediátrica y Cardiopatías Congénitas. Delphi Consensus modified in two rounds. The study was conducted in four phases: 1) constitution of a Scientific Committee for bibliographic review and submission of the recommendations for discussion, 2) constitution of an Expert Panel with 75 representatives in the speciality, 3) postal survey organised in two rounds and intermediate processing of opinions, and issuing of a report to the panellists, and 4) discussion of the results in a face-to-face meeting of the Scientific Committee. Consensus was reached on 54 of the 70 preventive recommendations analysed. With respect to the 16 remaining issues, no consensus was reached, due to differences in professional opinion and the absence of established criteria among the majority of the experts. A set of recommendations for RSV prophylaxis in cardiology was developed and updated, rated in accordance with the degree of professional consensus on which they were based. These can be considered valid until such time as new scientific information emerges that warrants a further review.</description><identifier>EISSN: 1695-9531</identifier><identifier>DOI: 10.1016/j.anpedi.2010.03.001</identifier><identifier>PMID: 20493788</identifier><language>spa</language><publisher>Spain</publisher><subject>Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Humanized ; Antiviral Agents - therapeutic use ; Child ; Humans ; Palivizumab ; Respiratory Syncytial Virus Infections - prevention &amp; control</subject><ispartof>Anales de pediatría (Barcelona, Spain : 2003), 2010-06, Vol.72 (6), p.432.e1-432.13</ispartof><rights>Copyright 2009 Asociación Española de Pediatría. Published by Elsevier Espana. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23930,23931,25140,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20493788$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Medrano López, C</creatorcontrib><creatorcontrib>García-Guereta, L</creatorcontrib><creatorcontrib>Fernández Pineda, L</creatorcontrib><creatorcontrib>Malo Concepción, P</creatorcontrib><creatorcontrib>Maroto Alvaro, E</creatorcontrib><creatorcontrib>Santos de Soto, J</creatorcontrib><creatorcontrib>Lirio Casero, J</creatorcontrib><creatorcontrib>Suárez Cabrera, P</creatorcontrib><creatorcontrib>Caballero Martínez, F</creatorcontrib><title>Clinical consensus on respiratory syncytial virus (RSV) infection prophylaxis and the use of palivizumab in paediatric cardiology.</title><title>Anales de pediatría (Barcelona, Spain : 2003)</title><addtitle>An Pediatr (Barc)</addtitle><description>Following the results of the CIVIC study, the SECPCC proposes to revise its recommendations for the prevention of RSV, taking into account the new evidence, as well as the preventive experience of paediatric cardiologists. For this purpose a structured method of professional consensus has been chosen. To develop a Spanish clinical consensus on preventing infection by RSV under the auspices of the Sociedad Española de Cardiología Pediátrica y Cardiopatías Congénitas. Delphi Consensus modified in two rounds. The study was conducted in four phases: 1) constitution of a Scientific Committee for bibliographic review and submission of the recommendations for discussion, 2) constitution of an Expert Panel with 75 representatives in the speciality, 3) postal survey organised in two rounds and intermediate processing of opinions, and issuing of a report to the panellists, and 4) discussion of the results in a face-to-face meeting of the Scientific Committee. Consensus was reached on 54 of the 70 preventive recommendations analysed. With respect to the 16 remaining issues, no consensus was reached, due to differences in professional opinion and the absence of established criteria among the majority of the experts. A set of recommendations for RSV prophylaxis in cardiology was developed and updated, rated in accordance with the degree of professional consensus on which they were based. These can be considered valid until such time as new scientific information emerges that warrants a further review.</description><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Humanized</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Child</subject><subject>Humans</subject><subject>Palivizumab</subject><subject>Respiratory Syncytial Virus Infections - prevention &amp; control</subject><issn>1695-9531</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNo1kEtLxDAUhYMgzjj6D0SyUxetebbpUgZfMCD42pa86mTopDVpB-vSX27AcXW493z3cjgAnGGUY4SL600ufW-NywlKK0RzhPABmOOi4lnFKZ6B4xg3CBFRkPIIzAhiFS2FmIOfZeu807KFuvPR-jhG2HkYbOxdkEMXJhgnr6fBJWTnQrIvn1_er6DzjdWDS2wfun49tfLLRSi9gcPawjFa2DWwl63bue9xK1U6SGPKKIfgNNQyGNe13ceUn4DDRrbRnu51Ad7ubl-XD9nq6f5xebPKeszQkFFEGSFaoIoXlJoKG12ZQmHGdaNMgwsuqCKEUMqVkpwra4S1rBQGSYWahi7Axd_fFPhztHGoty5q27bS226MdUkpQ4xhkcjzPTmqrTV1H9xWhqn-r43-AsS3chs</recordid><startdate>201006</startdate><enddate>201006</enddate><creator>Medrano López, C</creator><creator>García-Guereta, L</creator><creator>Fernández Pineda, L</creator><creator>Malo Concepción, P</creator><creator>Maroto Alvaro, E</creator><creator>Santos de Soto, J</creator><creator>Lirio Casero, J</creator><creator>Suárez Cabrera, P</creator><creator>Caballero Martínez, F</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201006</creationdate><title>Clinical consensus on respiratory syncytial virus (RSV) infection prophylaxis and the use of palivizumab in paediatric cardiology.</title><author>Medrano López, C ; García-Guereta, L ; Fernández Pineda, L ; Malo Concepción, P ; Maroto Alvaro, E ; Santos de Soto, J ; Lirio Casero, J ; Suárez Cabrera, P ; Caballero Martínez, F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p140t-303422c8095633d91dc9d6b145cfbdf16583b222335bba55bed8ee478d0ab0ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2010</creationdate><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Humanized</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Child</topic><topic>Humans</topic><topic>Palivizumab</topic><topic>Respiratory Syncytial Virus Infections - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Medrano López, C</creatorcontrib><creatorcontrib>García-Guereta, L</creatorcontrib><creatorcontrib>Fernández Pineda, L</creatorcontrib><creatorcontrib>Malo Concepción, P</creatorcontrib><creatorcontrib>Maroto Alvaro, E</creatorcontrib><creatorcontrib>Santos de Soto, J</creatorcontrib><creatorcontrib>Lirio Casero, J</creatorcontrib><creatorcontrib>Suárez Cabrera, P</creatorcontrib><creatorcontrib>Caballero Martínez, F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Anales de pediatría (Barcelona, Spain : 2003)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Medrano López, C</au><au>García-Guereta, L</au><au>Fernández Pineda, L</au><au>Malo Concepción, P</au><au>Maroto Alvaro, E</au><au>Santos de Soto, J</au><au>Lirio Casero, J</au><au>Suárez Cabrera, P</au><au>Caballero Martínez, F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical consensus on respiratory syncytial virus (RSV) infection prophylaxis and the use of palivizumab in paediatric cardiology.</atitle><jtitle>Anales de pediatría (Barcelona, Spain : 2003)</jtitle><addtitle>An Pediatr (Barc)</addtitle><date>2010-06</date><risdate>2010</risdate><volume>72</volume><issue>6</issue><spage>432.e1</spage><epage>432.13</epage><pages>432.e1-432.13</pages><eissn>1695-9531</eissn><abstract>Following the results of the CIVIC study, the SECPCC proposes to revise its recommendations for the prevention of RSV, taking into account the new evidence, as well as the preventive experience of paediatric cardiologists. For this purpose a structured method of professional consensus has been chosen. To develop a Spanish clinical consensus on preventing infection by RSV under the auspices of the Sociedad Española de Cardiología Pediátrica y Cardiopatías Congénitas. Delphi Consensus modified in two rounds. The study was conducted in four phases: 1) constitution of a Scientific Committee for bibliographic review and submission of the recommendations for discussion, 2) constitution of an Expert Panel with 75 representatives in the speciality, 3) postal survey organised in two rounds and intermediate processing of opinions, and issuing of a report to the panellists, and 4) discussion of the results in a face-to-face meeting of the Scientific Committee. Consensus was reached on 54 of the 70 preventive recommendations analysed. With respect to the 16 remaining issues, no consensus was reached, due to differences in professional opinion and the absence of established criteria among the majority of the experts. A set of recommendations for RSV prophylaxis in cardiology was developed and updated, rated in accordance with the degree of professional consensus on which they were based. These can be considered valid until such time as new scientific information emerges that warrants a further review.</abstract><cop>Spain</cop><pmid>20493788</pmid><doi>10.1016/j.anpedi.2010.03.001</doi></addata></record>
fulltext fulltext
identifier EISSN: 1695-9531
ispartof Anales de pediatría (Barcelona, Spain : 2003), 2010-06, Vol.72 (6), p.432.e1-432.13
issn 1695-9531
language spa
recordid cdi_proquest_miscellaneous_733404418
source ScienceDirect (Online service)
subjects Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
Antiviral Agents - therapeutic use
Child
Humans
Palivizumab
Respiratory Syncytial Virus Infections - prevention & control
title Clinical consensus on respiratory syncytial virus (RSV) infection prophylaxis and the use of palivizumab in paediatric cardiology.
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T11%3A04%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20consensus%20on%20respiratory%20syncytial%20virus%20(RSV)%20infection%20prophylaxis%20and%20the%20use%20of%20palivizumab%20in%20paediatric%20cardiology.&rft.jtitle=Anales%20de%20pediatr%C3%ADa%20(Barcelona,%20Spain%20:%202003)&rft.au=Medrano%20L%C3%B3pez,%20C&rft.date=2010-06&rft.volume=72&rft.issue=6&rft.spage=432.e1&rft.epage=432.13&rft.pages=432.e1-432.13&rft.eissn=1695-9531&rft_id=info:doi/10.1016/j.anpedi.2010.03.001&rft_dat=%3Cproquest_pubme%3E733404418%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p140t-303422c8095633d91dc9d6b145cfbdf16583b222335bba55bed8ee478d0ab0ff3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733404418&rft_id=info:pmid/20493788&rfr_iscdi=true